Concord Drugs informs about disclosures

16 Nov 2021

Concord Drugs has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Nagi Reddy.

The above information is a part of company’s filings submitted to BSE.


Related Concord Drugs Ltd. Links:

Concord Drugs Share Price

29.60 -1.30 (-4.21%) Nov 16, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 797.25
Cipla 921.05
Dr. Reddy's Lab 4819.30
Aurobindo Pharma 687.30
Lupin 932.05
View more..
Sensex vs Concord Drugs